Business
Novo Nordisk CEO Defends Lawsuit Against Eli Lilly
Novo Nordisk's CEO defended the company’s legal action against Eli Lilly over allegations of unfair competition in weight-loss drug advertising.
Coverage timeline — 2 articles
MarketWatch
‘Basic first class’ is here as airlines move to create multiple tiers of their most premium seats.
2026-08-13 10:30 UTC
CNBC
Novo Nordisk CEO defended the company's decision to sue rival Eli Lilly over its weight-loss drug advertising.
2026-08-12 22:53 UTC